Literature DB >> 25196945

Problems with the identification of 'problematic' cannabis use: examining the issues of frequency, quantity, and drug use environment.

Mark Asbridge1, Cameron Duff, David C Marsh, Patricia G Erickson.   

Abstract

Considerable recent attention has focused on how harmful or problematic cannabis use is defined and understood in the literature and put to use in clinical practice. The aim of the current study is to review conceptual and measurement shortcomings in the identification of problematic cannabis use, drawing on the WHO ASSIST instrument for specific examples. Three issues with the current approach are debated and discussed: (1) the identification of problematic cannabis use disproportionately relies on measures of the frequency of cannabis consumption rather than the harms experienced; (2) the quantity consumed on a typical day is not considered when assessing problematic use, and (3) screening tools for problematic use employ a 'one-size-fits-all approach' and fail to reflect on the drug use context (networks and environment). Our commentary tackles each issue, with a review of relevant literature coupled with analyses of two Canadian data sources--a representative sample of the Canadian adult population and a smaller sample of adult, regular, long-term cannabis users from four Canadian cities--to further articulate each point. This article concludes with a discussion of appropriate treatment interventions and approaches to reduce cannabis-related harms, and offers suggested changes to improve the measurement of problematic cannabis use.
© 2014 S. Karger AG, Basel.

Mesh:

Year:  2014        PMID: 25196945     DOI: 10.1159/000360697

Source DB:  PubMed          Journal:  Eur Addict Res        ISSN: 1022-6877            Impact factor:   3.015


  17 in total

1.  The Cannabis Abuse Screening Test (CAST) revisited: examining measurement invariance by age.

Authors:  Sharon R Sznitman
Journal:  Int J Methods Psychiatr Res       Date:  2016-10-10       Impact factor: 4.035

2.  Therapeutic use of cannabis: Prevalence and characteristics among adults in Ontario, Canada.

Authors:  Hayley A Hamilton; Bruna Brands; Anca R Ialomiteanu; Robert E Mann
Journal:  Can J Public Health       Date:  2017-09-14

Review 3.  Medical Marijuana and Marijuana Legalization.

Authors:  Rosalie Liccardo Pacula; Rosanna Smart
Journal:  Annu Rev Clin Psychol       Date:  2017-05-08       Impact factor: 18.561

4.  Marijuana use associated with worse verbal learning and delayed recall in a sample of young adults.

Authors:  Natalia Laspada; Erin Delker; Estela Blanco; Pamela Encina; Gabriela Caballero; Jorge Delva; Raquel Burrows; Betsy Lozoff; Sheila Gahagan
Journal:  Rev Med Chil       Date:  2019-02       Impact factor: 0.553

5.  Quantifying cannabis: A field study of marijuana quantity estimation.

Authors:  Mark A Prince; Bradley T Conner; Matthew R Pearson
Journal:  Psychol Addict Behav       Date:  2018-05-17

6.  Situating the Continuum of Overdose Risk in the Social Determinants of Health: A New Conceptual Framework.

Authors:  Ju Nyeong Park; Saba Rouhani; Leo Beletsky; Louise Vincent; Brendan Saloner; Susan G Sherman
Journal:  Milbank Q       Date:  2020-08-18       Impact factor: 4.911

7.  Early Risk Factors for Daily Cannabis Use in Young Adults.

Authors:  Erika Nicole Dugas; Marie-Pierre Sylvestre; Esthelle Ewusi-Boisvert; Michael Chaiton; Annie Montreuil; Jennifer O'Loughlin
Journal:  Can J Psychiatry       Date:  2018-10-29       Impact factor: 4.356

8.  Problematic substance use or problematic substance use policies?

Authors:  Tim Stockwell; Cecilia Benoit; Kiffer Card; Adam Sherk
Journal:  Health Promot Chronic Dis Prev Can       Date:  2020-06       Impact factor: 3.240

9.  Non-abstinent treatment outcomes for cannabis use disorder.

Authors:  Frances R Levin; John J Mariani; C Jean Choi; Cale Basaraba; Daniel J Brooks; Christina A Brezing; Martina Pavlicova
Journal:  Drug Alcohol Depend       Date:  2021-05-21       Impact factor: 4.852

Review 10.  Cannabis based medicines and cannabis dependence: A critical review of issues and evidence.

Authors:  Anne K Schlag; Chandni Hindocha; Rayyan Zafar; David J Nutt; H Valerie Curran
Journal:  J Psychopharmacol       Date:  2021-02-17       Impact factor: 4.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.